FI92696B - Förfarande för framställning av terapeutiskt användbara tiazolidindionderivat - Google Patents
Förfarande för framställning av terapeutiskt användbara tiazolidindionderivat Download PDFInfo
- Publication number
- FI92696B FI92696B FI904413A FI904413A FI92696B FI 92696 B FI92696 B FI 92696B FI 904413 A FI904413 A FI 904413A FI 904413 A FI904413 A FI 904413A FI 92696 B FI92696 B FI 92696B
- Authority
- FI
- Finland
- Prior art keywords
- methyl
- formula
- phenyl
- oxazolyl
- bond
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/44—Two oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Cleaning Or Clearing Of The Surface Of Open Water (AREA)
- Treatment Of Fiber Materials (AREA)
Claims (5)
1. Förfarande för framställning av en terapeutiskt användbar förening med formeln
5 K T <CIVn V / \ 1 (I) z väri den streckade Iinjen betecknar en bindning eller ingen bindning; V är -CH=CH-;
15 W är S, SO, S02, SOjNR1, NR^Oj, CONR1 eller NR^O; X är 0; Y är N, varvid en oxazol-4-ylgrupp bildas; Z är 2-fenyl; Z1 är 5-metyl;
20 R1 är självständigt väte eller (01-4) -alkyl; och n är 1 eller 2; ett farmaceutiskt godtagbart katjonsalt därav; eller ett farmaceutiskt godtagbart syraadditionssalt därav, när fö- reningen innehäller basiskt kväve; kännetecknat ...25 därav, att • · · a) när den streckade Iinjen betecknar en bindning, kondenseras tiazolidin-2,4-dion med en aldehyd eller keton med formeln
30 H .... .J-.r 35 92696 b) och när den streckade linjen icke betecknar en bindning, reduceras den ovan framställda föreningen med formeln (I), vari den streckade linjen betecknar en bindning; 5 c) när W är SOjNR1 eller CONR1 omsätts en aktiverad form av en syra med formeln />ch2V X^C ^SO,H -H, eller JCH2'n X'^S C02H -to?.. med en amin med formeln 0 20 ____ R j \„ eller HN / n1 25 - · · d) när W är NRxS02 eller NR^O, omsätts en aktiverad form av en syra med formeln 0 s—Λ) HOOC 35 eller • < II 92696 xVKi: b H0S02 v 0 med en amin med formeln 10 (CH ) 15 och, om önskvärt e) omvandlas en ovan framställd förening med formeln (I) till ett farmaceutiskt godtagbart katjonsalt; f) omvandlas en ovan framställd förening med formeln (I) vilken innehäller basiskt kväve, till ett far- 20 maceutiskt godtagbart syraadditionssalt; g) oxideras en ovan framställd förening med formeln (I), väri W är S, för bildande av en förening med formeln (I), väri W är SO eller S02.
2. Förfarande enligt patentkravet 1, känne-25 tecknat därav, att den streckade linjen icke be- tecknar en bindning.
3. Förfarande enligt patentkravet 2, känne-tecknat därav, att n är 1, W är CONR1.
4. Förfarande enligt patentkravet 2, känne-30 tecknat därav, att n är 1, W är NRxC0.
5. Förfarande enligt patentkravet 2, känne-tecknat därav, att n är 2, W är S eller S02. • .
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US1988/000745 WO1989008652A1 (en) | 1988-03-08 | 1988-03-08 | Thiazolidinedione derivatives as hypoglycemic agents |
| US8800745 | 1988-03-08 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI904413A0 FI904413A0 (sv) | 1990-09-07 |
| FI92696B true FI92696B (sv) | 1994-09-15 |
| FI92696C FI92696C (sv) | 1994-12-27 |
Family
ID=22208591
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI904413A FI92696C (sv) | 1988-03-08 | 1990-09-07 | Förfarande för framställning av terapeutiskt användbara tiazolidindionderivat |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0389699B1 (sv) |
| JP (1) | JPH01299289A (sv) |
| KR (1) | KR910000734B1 (sv) |
| CN (1) | CN1026234C (sv) |
| AU (1) | AU594899B2 (sv) |
| CA (1) | CA1328265C (sv) |
| DK (1) | DK108789A (sv) |
| ES (3) | ES2052906T3 (sv) |
| FI (1) | FI92696C (sv) |
| HU (1) | HU217432B (sv) |
| IL (1) | IL89481A (sv) |
| MY (1) | MY103837A (sv) |
| NO (1) | NO178068C (sv) |
| NZ (1) | NZ228247A (sv) |
| PT (1) | PT89922B (sv) |
| WO (1) | WO1989008652A1 (sv) |
| ZA (1) | ZA891681B (sv) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7026334B1 (en) | 1999-07-26 | 2006-04-11 | Shionogi & Co., Ltd. | Thiazolidine compounds and pharmaceutical compositions exhibiting thrombopoietin receptor agonism |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX15171A (es) * | 1988-03-08 | 1993-05-01 | Pfizer | Derivados de tiazolidinodiona hipoglicemicos |
| GB8919417D0 (en) * | 1989-08-25 | 1989-10-11 | Beecham Group Plc | Novel compounds |
| US5089514A (en) * | 1990-06-14 | 1992-02-18 | Pfizer Inc. | 3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents |
| AU645112B2 (en) * | 1990-08-23 | 1994-01-06 | Pfizer Inc. | Hypoglycemic hydroxyurea derivatives |
| FR2696743B1 (fr) * | 1992-10-12 | 1994-12-23 | Adir | Nouveaux composés de thiazolidine dione, leur procédé de préparation et les compositions pharmaceutiques les contenant. |
| DE4317320A1 (de) * | 1993-05-25 | 1994-12-01 | Boehringer Mannheim Gmbh | Neue Thiazolidindione und diese enthaltende Arzneimittel |
| JPH08157473A (ja) * | 1994-10-06 | 1996-06-18 | Nissan Chem Ind Ltd | ピラゾール系チアゾリジン類 |
| US5641796A (en) * | 1994-11-01 | 1997-06-24 | Eli Lilly And Company | Oral hypoglycemic agents |
| JP3906935B2 (ja) * | 1995-12-18 | 2007-04-18 | 杏林製薬株式会社 | Ｎ−置換ジオキソチアゾリジルベンズアミド誘導体及びその製造法 |
| AU2231397A (en) * | 1996-03-08 | 1997-09-22 | Torii Pharmaceutical Co., Ltd. | Thiazolidine-2,4-dione derivatives |
| DE19711616A1 (de) | 1997-03-20 | 1998-09-24 | Boehringer Mannheim Gmbh | Verbessertes Verfahren zur Herstellung von Thiazolidindionen |
| EP1103552A4 (en) * | 1998-08-07 | 2003-01-15 | Takeda Chemical Industries Ltd | BENZOTHIEPINE DERIVATIVES, METHOD FOR THEIR PRODUCTION AND THEIR USE |
| JP4316787B2 (ja) * | 2000-01-11 | 2009-08-19 | 壽製薬株式会社 | エーテル又はアミド誘導体、その製法並びにそれを含有する糖尿病治療剤、 |
| DE10029077A1 (de) | 2000-06-13 | 2001-12-20 | Bayer Ag | Thiazolylsubstituierte Heterocyclen |
| WO2002059100A1 (fr) * | 2001-01-26 | 2002-08-01 | Shionogi & Co., Ltd. | Composes halogene ayant un agonisme envers le recepteur de thrombopoietine |
| WO2002062775A1 (fr) * | 2001-02-02 | 2002-08-15 | Yamanouchi Pharmaceutical Co., Ltd. | Dérivé de 2-acylaminothiazole ou son sel |
| DE10331675A1 (de) | 2003-07-14 | 2005-02-10 | Bayer Cropscience Ag | Hetarylsubstituierte Pyrazolidindion-Derivate |
| WO2008051197A2 (en) | 2005-09-20 | 2008-05-02 | Mayo Foundation For Medical Education And Research | Small-molecule botulinum toxin inhibitors |
| GB2465890A (en) * | 2008-12-05 | 2010-06-09 | Scynexis Inc | 2-Arylazole derivatives as antiprotozoal agents |
| DE102022131780A1 (de) | 2022-11-30 | 2024-06-06 | HELLA GmbH & Co. KGaA | Induktiver Drehwinkelsensor |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1003445B (zh) * | 1984-10-03 | 1989-03-01 | 武田药品工业株式会社 | 噻唑烷二酮衍生物，其制备方法和用途 |
| US4703052A (en) * | 1985-05-21 | 1987-10-27 | Pfizer Inc. | Hypoglycemic thiazolidinediones |
| JPH06779B2 (ja) * | 1985-06-10 | 1994-01-05 | 武田薬品工業株式会社 | チアゾリジオン誘導体およびそれを含んでなる医薬組成物 |
-
1988
- 1988-03-08 HU HU181/88A patent/HU217432B/hu not_active IP Right Cessation
- 1988-03-08 WO PCT/US1988/000745 patent/WO1989008652A1/en active IP Right Grant
-
1989
- 1989-03-03 IL IL89481A patent/IL89481A/xx not_active IP Right Cessation
- 1989-03-06 MY MYPI89000272A patent/MY103837A/en unknown
- 1989-03-06 CA CA000592859A patent/CA1328265C/en not_active Expired - Fee Related
- 1989-03-06 ZA ZA891681A patent/ZA891681B/xx unknown
- 1989-03-07 DK DK108789A patent/DK108789A/da not_active Application Discontinuation
- 1989-03-07 AU AU31077/89A patent/AU594899B2/en not_active Ceased
- 1989-03-07 PT PT89922A patent/PT89922B/pt not_active IP Right Cessation
- 1989-03-07 NZ NZ228247A patent/NZ228247A/xx unknown
- 1989-03-07 KR KR1019890002788A patent/KR910000734B1/ko not_active IP Right Cessation
- 1989-03-07 CN CN89101214A patent/CN1026234C/zh not_active Expired - Fee Related
- 1989-03-08 JP JP1055973A patent/JPH01299289A/ja active Granted
- 1989-03-22 ES ES89302872T patent/ES2052906T3/es not_active Expired - Lifetime
- 1989-03-29 EP EP89303086A patent/EP0389699B1/en not_active Expired - Lifetime
- 1989-03-29 ES ES89303086T patent/ES2052907T3/es not_active Expired - Lifetime
- 1989-04-13 ES ES89303667T patent/ES2052910T3/es not_active Expired - Lifetime
-
1990
- 1990-09-05 NO NO903863A patent/NO178068C/no not_active IP Right Cessation
- 1990-09-07 FI FI904413A patent/FI92696C/sv not_active IP Right Cessation
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7026334B1 (en) | 1999-07-26 | 2006-04-11 | Shionogi & Co., Ltd. | Thiazolidine compounds and pharmaceutical compositions exhibiting thrombopoietin receptor agonism |
Also Published As
| Publication number | Publication date |
|---|---|
| WO1989008652A1 (en) | 1989-09-21 |
| DK108789A (da) | 1989-09-09 |
| ES2052907T3 (es) | 1994-07-16 |
| HU882181D0 (en) | 1991-01-28 |
| FI904413A0 (sv) | 1990-09-07 |
| JPH01299289A (ja) | 1989-12-04 |
| MY103837A (en) | 1993-09-30 |
| EP0389699B1 (en) | 1994-05-11 |
| HUT54680A (en) | 1991-03-28 |
| KR890014534A (ko) | 1989-10-24 |
| JPH0585551B2 (sv) | 1993-12-07 |
| AU3107789A (en) | 1989-09-14 |
| NO178068C (no) | 1996-01-17 |
| CA1328265C (en) | 1994-04-05 |
| CN1026234C (zh) | 1994-10-19 |
| KR910000734B1 (ko) | 1991-02-06 |
| IL89481A (en) | 1993-02-21 |
| FI92696C (sv) | 1994-12-27 |
| IL89481A0 (en) | 1989-09-10 |
| EP0389699A1 (en) | 1990-10-03 |
| NO903863L (no) | 1990-09-05 |
| CN1036572A (zh) | 1989-10-25 |
| PT89922B (pt) | 1995-03-01 |
| NZ228247A (en) | 1990-05-28 |
| NO178068B (no) | 1995-10-09 |
| ES2052906T3 (es) | 1994-07-16 |
| NO903863D0 (no) | 1990-09-05 |
| HU217432B (hu) | 2000-01-28 |
| AU594899B2 (en) | 1990-03-15 |
| PT89922A (pt) | 1989-11-10 |
| ZA891681B (en) | 1990-10-31 |
| ES2052910T3 (es) | 1994-07-16 |
| DK108789D0 (da) | 1989-03-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI92696B (sv) | Förfarande för framställning av terapeutiskt användbara tiazolidindionderivat | |
| US5330998A (en) | Thiazolidinedione derivatives as hypoglycemic agents | |
| KR910000723B1 (ko) | 혈당감소제 티아졸리딘디온 유도체 | |
| CA2029703C (en) | Oxazolidinedione hypoglycemic agents | |
| US5061717A (en) | Thiazolidinedione hypoglycemic agents | |
| US5223522A (en) | Thiazolidinedione hypoglycemic agents | |
| US5120754A (en) | Thiazolidinedione hypoglycemic agents | |
| US5036079A (en) | Hypoglycemic thiazolidinedione derivatives | |
| US5498621A (en) | Oxazolidinedione hypoglycemic agents | |
| JP2000507270A (ja) | 新規置換２，４―チアゾリジンジオン誘導体、その製造方法およびそれを含む薬剤組成物 | |
| US5130379A (en) | Hypoglycemic thiazolidinedione derivatives | |
| IE63187B1 (en) | Thiazolidinedione derivatives as hypoglycemic agents | |
| WO1991003474A1 (en) | Hypoglycemic thiazolidinedione derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BB | Publication of examined application | ||
| FG | Patent granted |
Owner name: PFIZER INC. |
|
| MA | Patent expired |